Using this assay in a cohort of patients with inflammatory and musculoskeletal diseases, we observe differences in the distribution and levels of total tenascin-C compared to tenascin-C variants that raise intriguing questions about the role of distinct proteoforms in inflammatory disease. Here, TNC is linked to musculoskeletal system disorder.